[1] Li X,Liu Y,Chen W,et al.TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer[J].Oncotarget,2014,5(19):9498-9513.
[2] 翁厚光,曹维克,张铁成,等.Oct4蛋白在胃癌及癌旁组织中的表达及其意义[J].江苏医药,2011,37(1):71-73.
[3] Hawkins KE,Joy S,Delhove JM,et al.NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogrammingr[J].Cell Rep,2016,14(8):1883-1891.
[4] Zhuge YH,Tao HQ,Wang YY.Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer[J].Zhonghua Yi Xue Za Zhi,2011,91(39): 2765-2768.
[5] Jiang WL,Zhang PF,Li GF,et al.Oct-4 is associated with gastric cancer progression and prognosis[J].Onco Targets Ther,2016,9: 517-522.
[6] Gazouli M,Roubelakis MG,Theodoropoulos GE,et al.OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer[J].Mol Carcinog,2012,51(2):165-173.
[7] 徐毅,丁伟基,李文鹏,等.干细胞转录因子Sox2、Oct4在不同分化程度胃癌组织中的表达及其临床意义[J].中国癌症杂志,2015,25(6):416-423.
[8] Shen W,Xi H,Wei B,et al.The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis[J].J Cancer Res Clin Oncol,2014,40(6):1003-1009.
[9] 姚宏亮,杨竹林,李永国.胃良恶性病变组织中PSCA和Oct-4的表达及意义[J].中南大学学报(医学版),2008,33(7):623-627.
[10] 王克畏,王元宁,叶再元,等.Oct4在胃癌组织中表达及其与浸润转移及预后的关系[J].浙江医学,2013,12(3):171-174.
[11] 刘劼,徐阿曼,陆震,等.胃癌及癌前病变组织中Nanog和Oct4的表达意义[J].临床与实验病理学杂志,2014,30(8):880-884.
[12] 吴炳霖. 干细胞基因Oct4过表达对胃癌细胞侵袭迁移的影响研究[D].福建医科大学,2014.
[13] 施益九,邱江锋,方雷,等.胚胎干细胞标志物转录因子在胃癌中的表达对细胞增殖和凋亡的影响[J].中华普通外科杂志,2015,30(7):554-556.
[14] 黄正接,王锐,罗维远,等.Oct4基因在胃癌细胞系中的表达及其意义[J].四川大学学报(医学版),2012,43(6):812-815.
[15] Hochedlinger K,Yamada Y,Beard C,et al.Ectopic expression of Oct4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues[J].Cell,2005,121(3):465-477.
[16] 张永杰,秦叔逵,王杰军,等.肠型胃癌中HDAC1与Oct4表达的相关性研究[J].中华临床医师杂志(电子版),2013,7(14):6387-6390.
[17] Asadi MH,Mowla SJ,Fathi F,et al.OCT4B1,a novel spliced variant of OCT4,is highly expressed in gastric cancer and acts as an antiapoptotic factor[J].Int J Cancer,2011,128(11):2645-2652.
[18] Bernhandt M,Galach M,Novak D,et al.Mediators of induced plunpotency and their role cancer cells-current scientifie knowledge and future perspectives[J].Biotechnol J,2012,7(6):810-821.
[19] McCann-Crosby B,Gunn S,Smith EO,et al.Association of immunohistochemical markers with premalignancy in Gonadal Dysgenesis[J].Int J Pediatr Endocrinol,2015,2015(1):14.
[20] Zhong J,Chen Y,Wang LJ.Emerging molecular basis of hematogenous metastasis in gastric cancer[J].World J Gastroenterol,2016,22(8):2434-2340. |
